pI: 9.2613 |
Length (AA): 710 |
MW (Da): 84306 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
5 | 692 | 1mw9 (X) | 3 | 584 | 23.00 | 0 | 1 | 0.84 | 0.7 |
5 | 710 | 4rul (A) | 3 | 595 | 22.00 | 0 | 1 | 0.911466 | 1.26 |
5 | 703 | 4cgy (A) | 35 | 637 | 41.00 | 0 | 1 | 1.29971 | 0.28 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | gametocyte, Female Gametocyte. | PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | early schizont, early trophozoite, late trophozoite, Male Gametocyte. | PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, late schizont, Oocyst. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, Ring, Sporozoite. | Otto TD Zanghi G |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_126736)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G63920 | topoisomerase 3alpha |
Arabidopsis thaliana | AT4G31210 | DNA topoisomerase, type IA, core |
Babesia bovis | BBOV_III001510 | DNA topoisomerase family protein |
Brugia malayi | Bm1_56415 | DNA topoisomerase III |
Candida albicans | CaO19.5934 | likely DNA topoisomerase III similar to S. cerevisiae TOP3 (YLR234W) involved in recombination repair events |
Candida albicans | CaO19.13355 | likely DNA topoisomerase III similar to S. cerevisiae TOP3 (YLR234W) involved in recombination repair events |
Caenorhabditis elegans | CELE_Y56A3A.27 | Protein TOP-3 |
Cryptosporidium hominis | Chro.50267 | DNA topoisomerase III |
Cryptosporidium parvum | cgd5_1180 | DNA topoisomerase III, putative |
Chlamydia trachomatis | CT_643 | DNA topoisomerase I |
Dictyostelium discoideum | DDB_G0275257 | DNA topoisomerase III |
Drosophila melanogaster | Dmel_CG10123 | Topoisomerase 3alpha |
Escherichia coli | b1274 | DNA topoisomerase I, omega subunit |
Escherichia coli | b1763 | DNA topoisomerase III |
Echinococcus granulosus | EgrG_000163600 | DNA topoisomerase 3 alpha |
Entamoeba histolytica | EHI_038920 | DNA topoisomerase III, putative |
Echinococcus multilocularis | EmuJ_000163600 | rho GTPase activating protein 20 |
Giardia lamblia | GL50803_7615 | DNA topoisomerase III |
Homo sapiens | ENSG00000177302 | topoisomerase (DNA) III alpha |
Leishmania braziliensis | LbrM.35.3420 | DNA topoisomerase III, putative |
Leishmania braziliensis | LbrM.21.0170 | DNA topoisomerase 1A |
Leishmania donovani | LdBPK_363350.1 | DNA topoisomerase III, putative |
Leishmania donovani | LdBPK_210180.1 | DNA topoisomerase 1A |
Leishmania infantum | LinJ.21.0180 | DNA topoisomerase 1A |
Leishmania infantum | LinJ.36.3350 | DNA topoisomerase III, putative |
Leishmania major | LmjF.21.0125 | DNA topoisomerase 1A |
Leishmania major | LmjF.36.3200 | DNA topoisomerase III, putative |
Leishmania mexicana | LmxM.21.0125 | DNA topoisomerase 1A |
Leishmania mexicana | LmxM.36.3200 | DNA topoisomerase III, putative |
Loa Loa (eye worm) | LOAG_03396 | DNA topoisomerase III |
Mycobacterium leprae | ML0200 | Probable DNA topoisomerase I TopA (omega-protein) (relaxing enzyme) (untwisting enzyme) (swivelase) (type I DNA topoisomerase) ( |
Mus musculus | ENSMUSG00000002814 | topoisomerase (DNA) III alpha |
Mycobacterium tuberculosis | Rv3646c | DNA topoisomerase I TopA (omega-protein) (relaxing enzyme) (untwisting enzyme) (swivelase) (type I DNA topoisomerase) (nicking-c |
Mycobacterium ulcerans | MUL_4222 | DNA topoisomerase I |
Neospora caninum | NCLIV_046480 | DNA topoisomerase III alpha, putative |
Oryza sativa | 9271035 | Os06g0281400 |
Oryza sativa | 9269718 | Os03g0165000 |
Plasmodium berghei | PBANKA_1360000 | DNA topoisomerase 3, putative |
Plasmodium falciparum | PF3D7_1347100 | DNA topoisomerase 3, putative |
Plasmodium knowlesi | PKNH_1253800 | DNA topoisomerase 3, putative |
Plasmodium vivax | PVX_083255 | DNA topoisomerase 3, putative |
Plasmodium yoelii | PY01134 | DNA topoisomerase iii |
Saccharomyces cerevisiae | YLR234W | DNA topoisomerase 3 |
Schistosoma japonicum | Sjp_0109870 | DNA topoisomerase 3-alpha, putative |
Schistosoma japonicum | Sjp_0113590 | DNA topoisomerase 3-alpha, putative |
Schistosoma japonicum | Sjp_0049450 | ko:K03165 DNA topoisomerase III, putative |
Schistosoma mansoni | Smp_158140 | prokaryotic DNA topoisomerase |
Schmidtea mediterranea | mk4.000689.04 | |
Schmidtea mediterranea | mk4.008541.03 | DNA topoisomerase 3-alpha |
Schmidtea mediterranea | mk4.017870.00 | Putative prokaryotic DNA topoisomerase |
Schmidtea mediterranea | mk4.000689.00 | DNA topoisomerase 3 |
Schmidtea mediterranea | mk4.000306.07 | Putative prokaryotic DNA topoisomerase |
Schmidtea mediterranea | mk4.000689.01 | Putative prokaryotic DNA topoisomerase |
Schmidtea mediterranea | mk4.059086.00 | |
Schmidtea mediterranea | mk4.008541.01 | Putative prokaryotic DNA topoisomerase |
Schmidtea mediterranea | mk4.000306.05 | DNA topoisomerase 3-alpha |
Trypanosoma brucei gambiense | Tbg972.11.10690 | DNA topoisomerase III, putative |
Trypanosoma brucei gambiense | Tbg972.10.2290 | DNA topoisomerase IA, putative |
Trypanosoma brucei | Tb927.10.1900 | DNA topoisomerase IA, putative |
Trypanosoma brucei | Tb927.11.9520 | DNA topoisomerase III, putative |
Trypanosoma congolense | TcIL3000.11.9990 | DNA topoisomerase III, putative |
Trypanosoma congolense | TcIL3000_10_1610 | DNA topoisomerase IA, putative |
Trypanosoma cruzi | TcCLB.510121.160 | DNA topoisomerase IA, putative |
Trypanosoma cruzi | TcCLB.508851.170 | DNA topoisomerase III, putative |
Trypanosoma cruzi | TcCLB.511589.120 | DNA topoisomerase III, putative |
Trypanosoma cruzi | TcCLB.506493.80 | DNA topoisomerase IA, putative |
Toxoplasma gondii | TGME49_226480 | DNA topoisomerase family protein |
Treponema pallidum | TP0394 | DNA topoisomerase I (topA) |
Theileria parva | TP03_0692 | DNA topoisomerase III, putative |
Trichomonas vaginalis | TVAG_306650 | prokaryotic DNA topoisomerase, putative |
Trichomonas vaginalis | TVAG_033330 | prokaryotic DNA topoisomerase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0037 | topoisomerase IA, TopA |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.1280 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1280 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1280 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb11.01.1280 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.1900 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.1900 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.1900 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.1900 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1274 | Escherichia coli | essential | goodall |
b1763 | Escherichia coli | non-essential | goodall |
PBANKA_1360000 | Plasmodium berghei | Slow | plasmo |
TGME49_226480 | Toxoplasma gondii | Essentiality uncertain | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Yersinia pestis | DNA topoisomerase | Compounds | References |
Trypanosoma cruzi | DNA topoisomerase IA, putative | Compounds | References |
Bos taurus | DNA topoisomerase | Compounds | References |
Trypanosoma brucei | DNA topoisomerase IA, putative | Compounds | References |
Trypanosoma cruzi | DNA topoisomerase IA, putative | Compounds | References |
29 literature references were collected for this gene.